| Application no. and date | 12703898.2 (espacenet) (Federated) (European Patent Register), 20120117 | | Patent/reg. no. and date | DK/EP 2667856, 20210728 | | Publication date | 20131204 | | Priority no. and date | JP 2011011711, 20110124 | | EP pub. no. and date |
EP 2667856 20131204 | | Effective date | | | Applicant/owner | Otsuka Pharmaceutical Co., Ltd., 9, Kanda-Tsukasamachi 2-chome
Chiyoda-ku
Tokyo 101-8535, JP | | Applicant ref. no. | P77373DK01 | | Inventor | HIRAOKA, Shogo, c/o OTSUKA PHARMACEUTICAL CO. LTD.
1-7-1 Doshomachi
Chuo-ku
Osaka-shi
Osaka 541-0045, JP,
TANIGUCHI, Kiyoshi, c/o OTSUKA PHARMACEUTICAL CO. LTD.
1-7-1 Doshomachi
Chuo-ku
Osaka-shi
Osaka 541-0045, JP | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/496 (2006.01) , A61K 9/19 (2006.01) , A61M 5/00 (2006.01) | | Title | MEDICINSK INDRETNING INDEHOLDENDE EN TØRSTOFSAMMENSÆTNING OMFATTENDE ARIPIPRAZOL SOM EN AKTIV INGREDIENS, OG EN TØRSTOFSAMMENSÆTNING OMFATTENDE ARIPIPRAZOL SOM EN AKTIV INGREDIENS | | Int. application no. | JP2012051285 | | Int. publication no. | WO2012102216 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
